Announced Sat, 9 Aug · 12:19 IST

Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Akums Drugs and Pharmaceuticals has submitted copies of newspaper advertisements published on August 9, 2025 in Financial Express (English) and Jansatta (Hindi), both New Delhi editions, as required under SEBI Listing Regulations. The advertisements relate to the unaudited financial results for the quarter ended June 30, 2025, which were approved by the Board on August 8, 2025. The ads include a QR code for easy access to the full results and are also hosted on the company's website. This is a standard regulatory compliance filing with no new financial figures disclosed in the announcement itself.

Likely market impact

This is a routine compliance disclosure and is unlikely to have any direct impact on the stock price. Investors should look at the actual Q1 FY26 financial results (already filed separately) for fundamental insights into the company's performance.